Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
Şahender Gülbin Aygencel BıkmazNazlıhan Boyacı DündarMelda TurkogluZeynep Arzu YeğinZübeyde Nur ÖzkurtAbdullah Münci YağcıPublished in: Turkish journal of medical sciences (2021)
A separate ICU allocated for haematology patients will allow timely and rapid admission of HM patients to ICU. Thus, mortality rates of HM patients needing ICU care will decline.